(3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone
C26H29FN4O — CID 91915578
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone
(3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone (PubChem CID 91915578) has the molecular formula C26H29FN4O and a molecular weight of 432.54 g/mol. Its IUPAC name is (3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone.
Molecular Properties
| Compound Name | (3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone |
|---|---|
| PubChem CID | 91915578 |
| Molecular Formula | C26H29FN4O |
| Molecular Weight | 432.54 g/mol |
| Exact Mass | 432.23 |
| IUPAC Name | (3-fluorophenyl)-[5-(2-methylpropyl)spiro[6H-imidazo[1,2-a][1,4]benzodiazepine-4,4'-piperidine]-1'-yl]methanone |
| SMILES | CC(C)CN1Cc2ccccc2-n2ccnc2C12CCN(C(=O)c1cccc(F)c1)CC2 |
| InChI | InChI=1S/C26H29FN4O/c1-19(2)17-30-18-21-6-3-4-9-23(21)31-15-12-28-25(31)26(30)10-13-29(14-11-26)24(32)20-7-5-8-22(27)16-20/h3-9,12,15-16,19H,10-11,13-14,17-18H2,1-2H3 |
| InChIKey | AWKZCSRVRYZLJP-UHFFFAOYSA-N |
| XLogP | 4.61 |
| TPSA | 41.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.54 |
| LogP ≤ 5 | 4.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91915578 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.